Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jul-24 2:50 PM View:  | Phathom Pharmaceuticals, Inc. (PHAT) | 15-Jul-24 | Sale | 33,848 | $11.72 | $396,699.00 | (8%) 415.42K to 381.57K | |
| 18-Jun-24 4:52 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 117% 8.69K to 18.83K | |
| 26-Mar-24 4:05 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Mar-24 | Sale | 16,851 | $9.11 | $153,513.00 | (4%) 431.48K to 414.62K | |
| 03-Nov-23 4:53 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Nov-23 | Grant | 37,500 | -- | -- | 10% 393.25K to 430.75K | |
| 17-Jul-23 5:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jul-23 | Grant | 200,000 | -- | -- | 103% 193.25K to 393.25K | |
| 02-Jun-23 7:10 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 31-May-23 | Grant | 4,375 | -- | -- | 101% 4.31K to 8.69K | |
| 07-Apr-23 3:19 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 06-Apr-23 | Private Purchase | 12,919 | $7.82 | $101,025.00 | 7% 177.61K to 190.53K | |
| 10-Mar-23 9:27 AM View: | Myovant Sciences Ltd. (MYOV) | 10-Mar-23 | Disposition | 3,673 | -- | -- | (100%) 3.67K to 0 | |
| 03-Mar-23 10:00 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Mar-23 | Sale (Planned) | 1,436 | $8.54 | $12,265.00 | (< 1%) 179.04K to 177.61K | |
| 20-Jan-23 7:39 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 20-Jan-23 | Sale | 5,821 | $8.20 | $47,729.30 | (3%) 184.86K to 179.04K | |
| 20-Jan-23 7:39 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-23 | Grant | 97,500 | -- | -- | 112% 87.36K to 184.86K | |
| 23-Nov-22 4:07 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Nov-22 | Sale | 1,526 | $9.60 | $14,649.60 | (2%) 87.48K to 85.96K | |
| 28-Oct-22 4:45 PM View: | Myovant Sciences Ltd. (MYOV) | 26-Oct-22 | Grant | 9,859 | -- | -- | 100% 0 to 9.86K | |
| 02-Sep-22 4:05 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Sep-22 | Grant | 7,500 | -- | -- | 9% 79.98K to 87.48K | |
| 03-Jun-22 4:58 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Jun-22 | Grant | 4,312 | -- | -- | 100% 0 to 4.31K | |
| 20-May-22 5:14 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-May-22 | Grant | 12,000 | -- | -- | 18% 65.32K to 77.32K | |
| 16-May-22 8:45 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 13-May-22 | Private Purchase | 20,500 | $7.41 | $151,835.00 | 46% 44.82K to 65.32K | |
| 21-Jan-22 6:47 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 19-Jan-22 | Grant | 41,250 | -- | -- | 1247% 3.31K to 44.56K | |
| 13-Sep-21 4:11 PM View: | Myovant Sciences Ltd. (MYOV) | 09-Sep-21 | Option Exercise | 4,850 | $7.65 | $37,102.50 | 100% 0 to 4.85K | |
| 13-Sep-21 4:11 PM View: | Myovant Sciences Ltd. (MYOV) | 09-Sep-21 | Market Option Sale (Planned) | 4,850 | $25.58 | $124,063.00 | (100%) 4.85K to 0 | |
| 03-Sep-21 10:00 PM View: | Myovant Sciences Ltd. (MYOV) | 02-Sep-21 | Option Exercise | 37,135 | $7.65 | $284,083.00 | 100% 0 to 37.13K | |
| 03-Sep-21 10:00 PM View: | Myovant Sciences Ltd. (MYOV) | 02-Sep-21 | Market Option Sale (Planned) | 37,135 | $25.03 | $929,489.00 | (100%) 37.13K to 0 | |
| 03-Sep-21 10:00 PM View: | Myovant Sciences Ltd. (MYOV) | 01-Sep-21 | Option Exercise | 11,373 | $7.65 | $87,003.50 | 100% 0 to 11.37K | |
| 03-Sep-21 10:00 PM View: | Myovant Sciences Ltd. (MYOV) | 01-Sep-21 | Market Option Sale (Planned) | 11,373 | $25.00 | $284,325.00 | (100%) 11.37K to 0 | |
| 23-Mar-21 7:22 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Mar-21 | Option Exercise | 11,513 | $6.95 | $80,015.40 | 100% 0 to 11.51K | |
| 23-Mar-21 7:22 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Mar-21 | Market Option Sale | 1,140 | $44.08 | $50,255.50 | (10%) 11.51K to 10.37K | |
| 23-Mar-21 7:22 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Mar-21 | Market Option Sale (Planned) | 10,373 | $43.24 | $448,495.00 | (100%) 10.37K to 0 | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 32,868 | -- | -- | 708% 4.64K to 37.51K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 37,181 | -- | -- | (99%) 37.51K to 0.33K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 327 | -- | -- | (100%) 0.33K to 0 | |
| 04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,123 | $108.03 | $121,318.00 | (18%) 6.36K to 5.24K | |
| 04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,281 | -- | -- | 106% 3.08K to 6.36K | |
| 19-Sep-19 4:05 PM View: | Celgene Corporation (CELG) | 18-Sep-19 | Option Exercise | 4,500 | $58.33 | $262,485.00 | 45% 9.92K to 14.42K | |
| 19-Sep-19 4:05 PM View: | Celgene Corporation (CELG) | 18-Sep-19 | Market Option Sale | 4,500 | $98.27 | $442,199.00 | (31%) 14.42K to 9.92K | |
| 19-Sep-19 4:05 PM View: | Celgene Corporation (CELG) | 18-Sep-19 | Market Sale | 6,838 | $98.27 | $671,945.00 | (69%) 9.92K to 3.08K | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Payment of Exercise | 490 | $95.21 | $46,652.90 | (5%) 10.41K to 9.92K | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Option Exercise | 1,563 | -- | -- | 18% 8.85K to 10.41K | |
| 18-Dec-18 6:28 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Payment of Exercise | 1,231 | $68.20 | $83,954.20 | (12%) 9.88K to 8.65K | (33%) |
| 18-Dec-18 6:28 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Option Exercise | 2,500 | -- | -- | 34% 7.38K to 9.88K | |
| 08-May-18 4:56 PM View: | Celgene Corporation (CELG) | 04-May-18 | Payment of Exercise | 856 | $86.89 | $74,377.80 | (10%) 8.24K to 7.38K | (4%) |
| 08-May-18 4:56 PM View: | Celgene Corporation (CELG) | 04-May-18 | Option Exercise | 2,500 | -- | -- | 44% 5.74K to 8.24K | |
| 20-Dec-17 4:03 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Payment of Exercise | 683 | $107.06 | $73,122.00 | (11%) 6.29K to 5.61K | 15% |
| 20-Dec-17 4:03 PM View: | Celgene Corporation (CELG) | 19-Dec-17 | Option Exercise | 1,765 | -- | -- | 39% 4.52K to 6.29K | |
| 26-Sep-17 4:29 PM View: | Celgene Corporation (CELG) | 25-Sep-17 | Market Sale | 1,727 | $143.89 | $248,498.00 | (28%) 6.25K to 4.52K | 37% |
| 02-Aug-17 4:38 PM View: | Celgene Corporation (CELG) | 01-Aug-17 | Payment of Exercise | 558 | $135.18 | $75,430.40 | (8%) 6.81K to 6.25K | 33% |
| 02-Aug-17 4:38 PM View: | Celgene Corporation (CELG) | 01-Aug-17 | Option Exercise | 1,500 | -- | -- | 28% 5.31K to 6.81K |